Biocon signs deal with Biomm SA to commercialise diabetes drug in Brazil | Company News04/18/2024 majac Diabetes Biomm said that Brazil ranks fifth globally in diabetes prevalence, with 16.8 million adults aged 20 to 79 affected by the disease. The figure is …Share on FacebookTweetFollow usSave